To schedule an appointment call Dr. Karr's office AT 863-646-5960 first to be initially seen in my office . We see you first in my office to determine if you need to be seen at the wound carte center by myself and if my office staff needs to secure the APPROPRIATE referral for you as well.
Do you need to go to the wound care center? - No. Currently the Lakeland wound care center has no leg, ankle, and foot surgical specialiist. When your wound goes beyond what the Lakeland wound care can treat, these patients are sent to the hopsital to be seen by a random surgeon. When you become my patient (Dr. Karr) I will take care of your wound in my office, in Lakeland Regional Health hospital, and I will be the one to perform surgery if neccessary.
Dr. Karr was formally the medical director of education, research, and development at the Lakeland wound care center. Programs that Dr. Karr were involved in at the wound care was the center of excellence for education, founded in 2010 by Dr. Karr. There is no service that Dr. Karr used to provide at the wound care center, except hyperbaric oxygen treatment, that we can provide in the office or the operating room setting . Your wound care can be successfully and quickly managed in Dr. Karr's office saving the patient time and money from expensive copays at the wound care center. If hyperbaric oxygen treatment is needed we will arrange for that treatment while continuing to provide wound care at out office. Since Dr. Karr's departure from the wound care center, the wound care center does not have a foot, ankle, leg surgeon. I have a 98% healing rate for wound at out office. Advanced and state of the art wound care treatment modalities are utilized by Dr. Karr to heal your chronic wound at either his office or the operating room.
Some of these advanced treatment choices are:
Apligraf®: an unique, advanced treatment for healing. It is created from cells found in healthy human skin. Which explains why it looks like a thin, piece of real skin. It is used to heal ulcers such as diabetic foot and venous leg ulcers that are not healing after 3-4 weeks, despite treatment with conventional therapies. Apligraf® contains two types of cells – an outer layer of protective skin cells, and an inner layer of cells contained within collagen. Both types of cells contain substances similiar to those found in human skin. Apligraf® does not contain certain things in skin such as hair follicles, sweat glands or blood vessels. Apligraf® plays an active role in healing by providing to the wound living cells, proteins produced by the cells, and collagen, which are important for healing.
REGRANEX® (becaplermin) Gel: recombinant growth factor, is indicated for the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and have an adequate blood supply, when used as an adjunct to, and not a substitute for, good ulcer care practices including initial sharp debridement, pressure relief and infection control. This effective medication does come with a FDA warning:
WARNING: INCREASED RATE OF MORTALITY SECONDARY TO MALIGNANCY
An increased rate of mortality secondary to malignancy was observed in patients treated with 3 or more tubes of REGRANEX® Gel in a postmarketing retrospective cohort study. REGRANEX Gel should only be used when the benefits can be expected to outweigh the risks. REGRANEX Gel should be used with caution in patients with known malignancy.
Dermagraft: Dermagraft is a cryopreserved human fibroblast-derived dermal substitute and is indicated for use in the treatment of full-thickness diabetic foot ulcers greater than six weeks duration, which extend through the dermis, but without tendon, muscle, joint capsule, or bone exposure.
Xenograft: Several types of xenografts i.e. Primatrix, medical prepared animal tissue, are an effective means of providing temporary wound coverage to facilitate healing.
Silverlon wound dressings: Silver has long been known to possess antimicrobial properties and silver is utilized in numerous medical products. Silver has broad antimicrobial properties against gram-positive and gram-negative bacteria. This dressing type can be an effective dressing by itself or in conjunction with other wound dressings.
Dr. Karr was formally the medical director of education, research, and development at the Lakeland wound care center. Programs that Dr. Karr were involved in at the wound care was the center of excellence for education, founded in 2010 by Dr. Karr. There is no service that Dr. Karr used to provide at the wound care center, except hyperbaric oxygen treatment, that we can provide in the office or the operating room setting . Your wound care can be successfully and quickly managed in Dr. Karr's office saving the patient time and money from expensive copays at the wound care center. If hyperbaric oxygen treatment is needed we will arrange for that treatment while continuing to provide wound care at out office. Since Dr. Karr's departure from the wound care center, the wound care center does not have a foot, ankle, leg surgeon. I have a 98% healing rate for wound at out office. Advanced and state of the art wound care treatment modalities are utilized by Dr. Karr to heal your chronic wound at either his office or the operating room.
Some of these advanced treatment choices are:
Apligraf®: an unique, advanced treatment for healing. It is created from cells found in healthy human skin. Which explains why it looks like a thin, piece of real skin. It is used to heal ulcers such as diabetic foot and venous leg ulcers that are not healing after 3-4 weeks, despite treatment with conventional therapies. Apligraf® contains two types of cells – an outer layer of protective skin cells, and an inner layer of cells contained within collagen. Both types of cells contain substances similiar to those found in human skin. Apligraf® does not contain certain things in skin such as hair follicles, sweat glands or blood vessels. Apligraf® plays an active role in healing by providing to the wound living cells, proteins produced by the cells, and collagen, which are important for healing.
REGRANEX® (becaplermin) Gel: recombinant growth factor, is indicated for the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and have an adequate blood supply, when used as an adjunct to, and not a substitute for, good ulcer care practices including initial sharp debridement, pressure relief and infection control. This effective medication does come with a FDA warning:
WARNING: INCREASED RATE OF MORTALITY SECONDARY TO MALIGNANCY
An increased rate of mortality secondary to malignancy was observed in patients treated with 3 or more tubes of REGRANEX® Gel in a postmarketing retrospective cohort study. REGRANEX Gel should only be used when the benefits can be expected to outweigh the risks. REGRANEX Gel should be used with caution in patients with known malignancy.
Dermagraft: Dermagraft is a cryopreserved human fibroblast-derived dermal substitute and is indicated for use in the treatment of full-thickness diabetic foot ulcers greater than six weeks duration, which extend through the dermis, but without tendon, muscle, joint capsule, or bone exposure.
Xenograft: Several types of xenografts i.e. Primatrix, medical prepared animal tissue, are an effective means of providing temporary wound coverage to facilitate healing.
Silverlon wound dressings: Silver has long been known to possess antimicrobial properties and silver is utilized in numerous medical products. Silver has broad antimicrobial properties against gram-positive and gram-negative bacteria. This dressing type can be an effective dressing by itself or in conjunction with other wound dressings.
